When the CRISPR-SONIC system (SgA, sgActin, Donor) is co-delivered with a sgRNA targeting a tumor suppressor (i.e., p53) for generation of tumor, CRISPR-SONIC can integrate at both sgRNA sites, sgActin and sgp53. The gene discussed is TP53; the disease is neoplasm.